Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Rodrigo Dienstmann

dienstmann-rodrigo

Rodrigo Dienstmann

Oncoclínicas Group, São Paulo

Brazil

Vall d’Hebron Institute of Oncology, Barcelona

Spain

Rodrigo Dienstmann is a medical oncologist with expertise in early drug development and molecularly-guided therapies. His research is focused on integrating biomarker data with clinical outcomes to boost precision cancer therapy. He is currently working as a researcher in the Oncology Data Science Group, at the Vall d´Hebron Institute of Oncology in Barcelona, Spain. At the same time, he is also working as medical director of Oncoclínicas Precision Medicine and Big Data Initiatives, in São Paulo, Brazil.

Last update: June 2023

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.

  • Analytics cookies help us improve our website by collecting and reporting information on its usage.

  • We use marketing cookies to build a profile of you as a user through your actions on our site in order to better understand your interests and provide you with pertinent suggestions.